Tapewire

Nasdaq · USD

APRE

Aprea Therapeutics, Inc.

Export transactions ↓
Tapewire entity
7948
SEC CIK
0001781983
Parsed reports
180

Last 12 months

Inside the activity.

4 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202520
Jan 202620
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 30, 2021 Filed Jul 1, 2021 23:07 UTC GrantCommon Stock 4,610 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-012874 · doc1.xml · nonDerivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,610

F1 · shares: These shares represent restricted stock units which were granted on June 30, 2021, and which will vest and be settled in common stock on June 30, 2022, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
June 30, 2021 Filed Jul 1, 2021 23:00 UTC GrantStock Option (Right to Buy) · Derivative 22,750 $0.00 Strike: $4.88 $0.00
Disclosure

SEC source: 0001567619-21-012872 · doc1.xml · derivative · entry 2

Seizinger Bernd R. · CIK 0001789042 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,750

Underlying: Common Stock · 22,750 shares

Expires 2031-06-30

F2 · derivative.exercise_date: The option vests in full on June 30, 2022, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
June 30, 2021 Filed Jul 1, 2021 23:00 UTC GrantCommon Stock 4,610 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-012872 · doc1.xml · nonDerivative · entry 1

Seizinger Bernd R. · CIK 0001789042 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268,580

F1 · shares: These shares represent restricted stock units which were granted on June 30, 2021, and which will vest and be settled in common stock on June 30, 2022, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
March 10, 2021 Filed Mar 11, 2021 22:30 UTC
Korbel Gregory AlanChief Business Officer
GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0000905148-21-000282 · form4.xml · nonDerivative · entry 1

Korbel Gregory Alan · CIK 0001789032 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,500

F1 · shares: These shares represent restricted stock units which were granted on March 10, 2021, and which will vest and be settled in common stock as follows: (i) 5,000 shares on September 10, 2021, (ii) 5,000 shares on March 10, 2022 and (iii) 5,000 shares on September 10, 2022, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

Read SEC document
February 25, 2021 Filed Mar 2, 2021 00:05 UTC
SCHADE CHRISTIAN SDirector · Chairman & CEO
GrantStock Option (right to Buy) · Derivative 329,000 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0001140361-21-006730 · form4.xml · derivative · entry 10

SCHADE CHRISTIAN S · CIK 0001214496 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 329,000

Underlying: Common Stock · 329,000 shares

Expires 2031-02-25

F3 · derivative.exercise_date: Twenty-five percent of these options vest on February 25, 2022, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
February 25, 2021 Filed Mar 2, 2021 00:05 UTC
SCHADE CHRISTIAN SDirector · Chairman & CEO
GrantCommon Stock 88,500 $0.00 $0.00
Disclosure

SEC source: 0001140361-21-006730 · form4.xml · nonDerivative · entry 2

SCHADE CHRISTIAN S · CIK 0001214496 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,660

F2 · shares: These shares represent restricted stock units which were granted on February 25, 2021, and which will vest and be settled in common stock as follows: (i) 29,500 shares on August 25, 2021, (ii) 29,500 shares on February 25, 2022 and (iii) 29,500 shares on August 25, 2022, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

Read SEC document
February 25, 2021 Filed Mar 2, 2021 00:05 UTC
SCHADE CHRISTIAN SDirector · Chairman & CEO
GrantCommon Stock 77,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-21-006730 · form4.xml · nonDerivative · entry 1

SCHADE CHRISTIAN S · CIK 0001214496 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,160

F1 · shares: These shares represent restricted stock units which were granted on February 25, 2021, and which will vest and be settled in common stock as follows: (i) 25,666 shares on February 25, 2022, (ii) 25,667 shares on February 25, 2023 and (iii) 25,667 shares on February 25, 2024, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

Read SEC document
February 25, 2021 Filed Mar 1, 2021 19:03 UTC
Coiante Scott MSVP, Chief Financial Officer
GrantStock Option (right to Buy) · Derivative 143,000 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0001140361-21-006728 · form4.xml · derivative · entry 3

Coiante Scott M · CIK 0001608536 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,000

Underlying: Common Stock · 143,000 shares

Expires 2031-02-25

F3 · derivative.exercise_date: Twenty-five percent of these options vest on February 25, 2022, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
February 25, 2021 Filed Mar 1, 2021 19:03 UTC
Coiante Scott MSVP, Chief Financial Officer
GrantCommon Stock 63,500 $0.00 $0.00
Disclosure

SEC source: 0001140361-21-006728 · form4.xml · nonDerivative · entry 2

Coiante Scott M · CIK 0001608536 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,000

F2 · shares: These shares represent restricted stock units which were granted on February 25, 2021, and which will vest and be settled in common stock as follows: (i) 21,166 shares on August 25, 2021, (ii) 21,167 shares on February 25, 2022 and (iii) 21,167 shares on August 25, 2022, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

Read SEC document
February 25, 2021 Filed Mar 1, 2021 19:03 UTC
Coiante Scott MSVP, Chief Financial Officer
GrantCommon Stock 33,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-21-006728 · form4.xml · nonDerivative · entry 1

Coiante Scott M · CIK 0001608536 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,500

F1 · shares: These shares represent restricted stock units which were granted on February 25, 2021, and which will vest and be settled in common stock as follows: (i) 11,000 shares on February 25, 2022, (ii) 11,000 shares on February 25, 2023 and (iii) 11,000 shares on February 25, 2024, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

Read SEC document
February 25, 2021 Filed Mar 2, 2021 00:12 UTC
Attar Eyal C.SVP, Chief Medical Officer
GrantStock Option (right to Buy) · Derivative 143,000 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0001140361-21-006738 · form4.xml · derivative · entry 5

Attar Eyal C. · CIK 0001789076 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,000

Underlying: Common Stock · 143,000 shares

Expires 2031-02-25

F3 · derivative.exercise_date: Twenty-five percent of these options vest on February 25, 2022, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
February 25, 2021 Filed Mar 2, 2021 00:12 UTC
Attar Eyal C.SVP, Chief Medical Officer
GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-21-006738 · form4.xml · nonDerivative · entry 2

Attar Eyal C. · CIK 0001789076 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,000

F2 · shares: These shares represent restricted stock units which were granted on February 25, 2021, and which will vest and be settled in common stock as follows: (i) 25,000 shares on August 25, 2021, (ii) 25,000 shares on February 25, 2022 and (iii) 25,000 shares on August 25, 2022, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

Read SEC document
February 25, 2021 Filed Mar 2, 2021 00:12 UTC
Attar Eyal C.SVP, Chief Medical Officer
GrantCommon Stock 33,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-21-006738 · form4.xml · nonDerivative · entry 1

Attar Eyal C. · CIK 0001789076 · SVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,000

F1 · shares: These shares represent restricted stock units which were granted on February 25, 2021, and which will vest and be settled in common stock as follows: (i) 11,000 shares on February 25, 2022, (ii) 11,000 shares on February 25, 2023 and (iii) 11,000 shares on February 25, 2024, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

Read SEC document
February 25, 2021 Filed Mar 2, 2021 00:10 UTC
Wessels Gregory S.SVP, Chief Commercial Officer
GrantStock Option (right to Buy) · Derivative 66,000 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0001140361-21-006735 · form4.xml · derivative · entry 2

Wessels Gregory S. · CIK 0001824615 · SVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,000

Underlying: Common Stock · 66,000 shares

Expires 2031-02-25

F2 · derivative.exercise_date: Twenty-five percent of these options vest on February 25, 2022, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
February 25, 2021 Filed Mar 2, 2021 00:10 UTC
Wessels Gregory S.SVP, Chief Commercial Officer
GrantCommon Stock 16,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-21-006735 · form4.xml · nonDerivative · entry 1

Wessels Gregory S. · CIK 0001824615 · SVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

F1 · shares: These shares represent restricted stock units which were granted on February 25, 2021, and which will vest and be settled in common stock as follows: (i) 5,333 shares on February 25, 2022, (ii) 5,333 shares on February 25, 2023 and 5,334 shares on February 25, 2024, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

Read SEC document
February 25, 2021 Filed Mar 2, 2021 00:08 UTC
Abrahmsen Lars B.SVP, Chief Scientific Officer
GrantStock Option (right to Buy) · Derivative 82,000 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0001140361-21-006732 · form4.xml · derivative · entry 2

Abrahmsen Lars B. · CIK 0001789039 · SVP, Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,000

Underlying: Common Stock · 82,000 shares

Expires 2031-02-25

F2 · derivative.exercise_date: Twenty-five percent of these options vest on February 25, 2022, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
February 25, 2021 Filed Mar 2, 2021 00:08 UTC
Abrahmsen Lars B.SVP, Chief Scientific Officer
GrantCommon Stock 19,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-21-006732 · form4.xml · nonDerivative · entry 1

Abrahmsen Lars B. · CIK 0001789039 · SVP, Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,000

F1 · shares: These shares represent restricted stock units which were granted on February 25, 2021, and which will vest and be settled in common stock as follows: (i) 6,333 shares on February 25, 2022, (ii) 6,333 shares on February 25, 2023 and (iii) 6,334 shares on February 25, 2024, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

Read SEC document
February 25, 2021 Filed Mar 2, 2021 00:01 UTC
Korbel Gregory AlanVP of Business Dev't
GrantStock Option (right to Buy) · Derivative 41,100 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0001140361-21-006726 · form4.xml · derivative · entry 2

Korbel Gregory Alan · CIK 0001789032 · VP of Business Dev't

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,100

Underlying: Common Stock · 41,100 shares

Expires 2031-02-25

F2 · derivative.exercise_date: Twenty-five percent of these options vest on February 25, 2022, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
February 25, 2021 Filed Mar 2, 2021 00:01 UTC
Korbel Gregory AlanVP of Business Dev't
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-21-006726 · form4.xml · nonDerivative · entry 1

Korbel Gregory Alan · CIK 0001789032 · VP of Business Dev't

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,500

F1 · shares: These shares represent restricted stock units which were granted on February 25, 2021, and which will vest and be settled in common stock as follows: (i) 3,333 shares on August 25, 2021, (ii) 3,333 shares on February 25, 2022 and (iii) 3,334 shares on August 25, 2022, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

Read SEC document
December 28, 2020 Filed Feb 16, 2021 21:11 UTC
Green Jeremy10% owner
SaleCommon Stock 5,863 $5.80 $34,005.40
Disclosure

SEC source: 0001104659-21-023991 · tm215825-38_4seq1.xml · nonDerivative · entry 2

Redmile Group, LLC · CIK 0001425738 · 10% owner

Green Jeremy · CIK 0001650527 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,768,718

F1 · ownership.nature: These securities are directly owned by certain private investment vehicles managed by Redmile Group, LLC ("Redmile") and may be deemed beneficially owned by Redmile as investment manager of such private investment vehicles. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
December 28, 2020 Filed Feb 16, 2021 21:11 UTC
Green Jeremy10% owner
SaleCommon Stock 494,137 $5.58 $2,757,284.46
Disclosure

SEC source: 0001104659-21-023991 · tm215825-38_4seq1.xml · nonDerivative · entry 1

Redmile Group, LLC · CIK 0001425738 · 10% owner

Green Jeremy · CIK 0001650527 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,774,581

F1 · ownership.nature: These securities are directly owned by certain private investment vehicles managed by Redmile Group, LLC ("Redmile") and may be deemed beneficially owned by Redmile as investment manager of such private investment vehicles. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
October 05, 2020 Filed Oct 8, 2020 01:30 UTC
5AM Ventures IV, L.P.Former 10% holder
5AM Co-Investors IV, L.P.Former 10% holder
5AM Partners IV, LLCFormer 10% holder
5AM Opportunities I, L.P.Former 10% holder
DIEKMAN JOHN DFormer 10% holder
Schwab Andrew J.Former 10% holder
PARMAR KUSHFormer 10% holder
ROCKLAGE SCOTT MFormer 10% holder
SaleCommon Stock 175,000 $25.30 $4,427,500.00
Disclosure

SEC source: 0001104659-20-113186 · a4.xml · nonDerivative · entry 1

5AM Ventures IV, L.P. · CIK 0001589315 · Former 10% holder

5AM Co-Investors IV, L.P. · CIK 0001593361 · Former 10% holder

5AM Partners IV, LLC · CIK 0001589314 · Former 10% holder

5AM Opportunities I, L.P. · CIK 0001753000 · Former 10% holder

5AM Opportunities I (GP), LLC · CIK 0001790778 · Former 10% holder

DIEKMAN JOHN D · CIK 0001240357 · Former 10% holder

Schwab Andrew J. · CIK 0001598549 · Former 10% holder

PARMAR KUSH · CIK 0001664281 · Former 10% holder

ROCKLAGE SCOTT M · CIK 0001219014 · Former 10% holder

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 138,497

F1 · ownership.direct: Shares are held directly by 5AM Opportunities I, L.P. ("Opportunities"), which is under common control with the 5AM IV Funds. The 5AM IV Funds and Opportunities expressly disclaim status as a "group" for purposes of this Form 4.

F2 · ownership.direct: 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held directly by Opportunities, except to the extent of its or his pecuniary interest therein.

F1 · ownership.nature: Shares are held directly by 5AM Opportunities I, L.P. ("Opportunities"), which is under common control with the 5AM IV Funds. The 5AM IV Funds and Opportunities expressly disclaim status as a "group" for purposes of this Form 4.

F2 · ownership.nature: 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held directly by Opportunities, except to the extent of its or his pecuniary interest therein.

Read SEC document
September 28, 2020 Filed Sep 29, 2020 21:01 UTC GrantStock Option (right to Buy) · Derivative 12,000 $0.00 Strike: $22.65 $0.00
Disclosure

SEC source: 0000905148-20-001049 · form4.xml · derivative · entry 1

Kelly Michael Aaron · CIK 0001769668 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2030-09-28

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on September 28, 2021 subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
September 16, 2020 Filed Sep 18, 2020 21:05 UTC
Wessels Gregory S.SVP, Chief Commercial Officer
GrantStock Option (right to Buy) · Derivative 14,700 $0.00 Strike: $28.75 $0.00
Disclosure

SEC source: 0000905148-20-001030 · form4.xml · derivative · entry 1

Wessels Gregory S. · CIK 0001824615 · SVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,700

Underlying: Common Stock · 14,700 shares

Expires 2030-09-16

F1 · derivative.exercise_date: Twenty-five percent of these options vest on September 16, 2021, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
July 07, 2020 Filed Jul 7, 2020 21:41 UTC SaleCommon Stock 241,703 $34.55 $8,350,838.65
Disclosure

SEC source: 0001123292-20-000973 · edgar.xml · nonDerivative · entry 1

KDev Investments AB · CIK 0001789888 · 10% owner

Karolinska Development AB · CIK 0001789932 · 10% owner

KCIF Co-Investment Fund KB · CIK 0001789966 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,992,586

F1 · security: The amount of securities of Aprea Therapeutics, Inc. (the "Issuer") reported as beneficially owned includes shares held of record by: KDev Investments AB, Karolinska Development AB and KCIF Co-Investment Fund KB (collectively, the "Reporting Persons").

F2 · ownership.nature: Karolinska Development AB ("Karolinska") is the majority owner and co-manager of KDev Investments AB and a limited partner of KCIF Co-Investment Fund KB. Karolinska and each of the other Reporting Persons disclaim beneficial ownership of any shares of the Issuer's Common Stock owned of record by any of the other Reporting Persons except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that any such entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. The address of each of (i) KDev Investments AB, (ii) Karolinska Development AB, and (iii) KCIF Co-Investment Fund KB is Tomtebodavagen 23A, SE 171 65 Solna, Sweden.

Read SEC document
June 30, 2020 Filed Jul 1, 2020 18:01 UTC GrantStock Option (right to Buy) · Derivative 5,600 $0.00 Strike: $38.78 $0.00
Disclosure

SEC source: 0000905148-20-000749 · form4.xml · derivative · entry 1

Christenson Johan · CIK 0001488771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,600

Underlying: Common Stock · 5,600 shares

Expires 2030-06-30

F1 · derivative.exercise_date: The option vests in full on June 30, 2021 subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
June 30, 2020 Filed Jul 1, 2020 22:08 UTC GrantStock Option (right to Buy) · Derivative 5,600 $0.00 Strike: $38.78 $0.00
Disclosure

SEC source: 0000905148-20-000752 · form4.xml · derivative · entry 1

HENNEMAN JOHN B III · CIK 0001187572 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,600

Underlying: Common Stock · 5,600 shares

Expires 2030-06-30

F1 · derivative.exercise_date: The option vests in full on June 30, 2021 subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
June 30, 2020 Filed Jul 1, 2020 20:55 UTC GrantStock Option (right to Buy) · Derivative 5,600 $0.00 Strike: $38.78 $0.00
Disclosure

SEC source: 0000905148-20-000747 · form4.xml · derivative · entry 1

ROCKLAGE SCOTT M · CIK 0001219014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,600

Underlying: Common Stock · 5,600 shares

Expires 2030-06-30

F1 · derivative.exercise_date: The option vests in full on June 30, 2021 subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
June 30, 2020 Filed Jul 1, 2020 22:03 UTC GrantStock Option (right to Buy) · Derivative 5,600 $0.00 Strike: $38.78 $0.00
Disclosure

SEC source: 0000905148-20-000750 · form4.xml · derivative · entry 1

Hepple Jonathan · CIK 0001789045 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,600

Underlying: Common Stock · 5,600 shares

Expires 2030-06-30

F1 · derivative.exercise_date: The option vests in full on June 30, 2021 subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
June 30, 2020 Filed Jul 1, 2020 22:06 UTC GrantStock Option (right to Buy) · Derivative 5,600 $0.00 Strike: $38.78 $0.00
Disclosure

SEC source: 0000905148-20-000751 · form4.xml · derivative · entry 1

Seizinger Bernd R. · CIK 0001789042 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,600

Underlying: Common Stock · 5,600 shares

Expires 2030-06-30

F1 · derivative.exercise_date: The option vests in full on June 30, 2021 subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
June 26, 2020 Filed Jun 29, 2020 18:05 UTC GrantStock Option (right to Buy) · Derivative 7,000 $0.00 Strike: $38.32 $0.00
Disclosure

SEC source: 0000905148-20-000733 · form4.xml · derivative · entry 1

Namouni Fouad · CIK 0001815851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

Underlying: Common Stock · 7,000 shares

Expires 2030-06-26

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on June 26, 2021 subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
June 26, 2020 Filed Jun 29, 2020 22:04 UTC GrantStock Option (right to Buy) · Derivative 7,000 $0.00 Strike: $38.32 $0.00
Disclosure

SEC source: 0000905148-20-000732 · form4.xml · derivative · entry 1

Peters Richard · CIK 0001697628 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

Underlying: Common Stock · 7,000 shares

Expires 2030-06-26

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on June 26, 2021 subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Read SEC document
June 16, 2020 Filed Jun 18, 2020 23:22 UTC
PARMAR KUSH10% owner
SaleCommon Stock 19,836 $33.30 $660,538.80
Disclosure

SEC source: 0001209191-20-037714 · doc4.xml · nonDerivative · entry 3

5AM Ventures IV, L.P. · CIK 0001589315 · 10% owner

5AM Co-Investors IV, L.P. · CIK 0001593361 · 10% owner

5AM Partners IV, LLC · CIK 0001589314 · 10% owner

DIEKMAN JOHN D · CIK 0001240357 · 10% owner

Schwab Andrew J. · CIK 0001598549 · 10% owner

5AM Opportunities I, L.P. · CIK 0001753000 · 10% owner

5AM Opportunities I (GP), LLC · CIK 0001790778 · 10% owner

PARMAR KUSH · CIK 0001664281 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 313,497

F4 · ownership.direct: Shares are held directly by 5AM Opportunities I, L.P. ("Opportunities"), which is under common control with the 5AM IV Funds. The 5AM IV Funds and Opportunities expressly disclaim status as a "group" for purposes of this Form 4.

F5 · ownership.direct: 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held directly by Opportunities, except to the extent of its or his pecuniary interest therein.

F4 · ownership.nature: Shares are held directly by 5AM Opportunities I, L.P. ("Opportunities"), which is under common control with the 5AM IV Funds. The 5AM IV Funds and Opportunities expressly disclaim status as a "group" for purposes of this Form 4.

F5 · ownership.nature: 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held directly by Opportunities, except to the extent of its or his pecuniary interest therein.

Read SEC document
June 16, 2020 Filed Jun 18, 2020 23:22 UTC
PARMAR KUSH10% owner
SaleCommon Stock 4,807 $33.30 $160,073.10
Disclosure

SEC source: 0001209191-20-037714 · doc4.xml · nonDerivative · entry 2

5AM Ventures IV, L.P. · CIK 0001589315 · 10% owner

5AM Co-Investors IV, L.P. · CIK 0001593361 · 10% owner

5AM Partners IV, LLC · CIK 0001589314 · 10% owner

DIEKMAN JOHN D · CIK 0001240357 · 10% owner

Schwab Andrew J. · CIK 0001598549 · 10% owner

5AM Opportunities I, L.P. · CIK 0001753000 · 10% owner

5AM Opportunities I (GP), LLC · CIK 0001790778 · 10% owner

PARMAR KUSH · CIK 0001664281 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 75,965

F2 · ownership.direct: 5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.

F3 · ownership.direct: Shares are held directly by 5AM Co-Investors IV, L.P.

F2 · ownership.nature: 5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.

F3 · ownership.nature: Shares are held directly by 5AM Co-Investors IV, L.P.

Read SEC document
June 16, 2020 Filed Jun 18, 2020 23:22 UTC
PARMAR KUSH10% owner
SaleCommon Stock 115,357 $33.30 $3,841,388.10
Disclosure

SEC source: 0001209191-20-037714 · doc4.xml · nonDerivative · entry 1

5AM Ventures IV, L.P. · CIK 0001589315 · 10% owner

5AM Co-Investors IV, L.P. · CIK 0001593361 · 10% owner

5AM Partners IV, LLC · CIK 0001589314 · 10% owner

DIEKMAN JOHN D · CIK 0001240357 · 10% owner

Schwab Andrew J. · CIK 0001598549 · 10% owner

5AM Opportunities I, L.P. · CIK 0001753000 · 10% owner

5AM Opportunities I (GP), LLC · CIK 0001790778 · 10% owner

PARMAR KUSH · CIK 0001664281 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,823,192

F1 · ownership.direct: Shares are held directly by 5AM Ventures IV, L.P.

F2 · ownership.direct: 5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.

F1 · ownership.nature: Shares are held directly by 5AM Ventures IV, L.P.

F2 · ownership.nature: 5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.

Read SEC document
June 16, 2020 Filed Jun 18, 2020 23:23 UTC
ROCKLAGE SCOTT MDirector · 10% owner
SaleCommon Stock 4,807 $33.30 $160,073.10
Disclosure

SEC source: 0001209191-20-037715 · doc4.xml · nonDerivative · entry 2

ROCKLAGE SCOTT M · CIK 0001219014 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnotes

Disclosed balance after: 75,965

F2 · ownership.direct: The reporting person is a managing member of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM Funds. The reporting person disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM Funds, except to the extent of his pecuniary interest therein.

F3 · ownership.direct: Shares are held directly by 5AM Co-Investors IV, L.P

F2 · ownership.nature: The reporting person is a managing member of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM Funds. The reporting person disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM Funds, except to the extent of his pecuniary interest therein.

F3 · ownership.nature: Shares are held directly by 5AM Co-Investors IV, L.P

Read SEC document
June 16, 2020 Filed Jun 18, 2020 23:23 UTC
ROCKLAGE SCOTT MDirector · 10% owner
SaleCommon Stock 115,357 $33.30 $3,841,388.10
Disclosure

SEC source: 0001209191-20-037715 · doc4.xml · nonDerivative · entry 1

ROCKLAGE SCOTT M · CIK 0001219014 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnotes

Disclosed balance after: 1,823,192

F1 · ownership.direct: Shares are held directly by 5AM Ventures IV, L.P.

F2 · ownership.direct: The reporting person is a managing member of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM Funds. The reporting person disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM Funds, except to the extent of his pecuniary interest therein.

F1 · ownership.nature: Shares are held directly by 5AM Ventures IV, L.P.

F2 · ownership.nature: The reporting person is a managing member of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM Funds. The reporting person disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM Funds, except to the extent of his pecuniary interest therein.

Read SEC document
June 11, 2020 Filed Jun 16, 2020 01:12 UTC
PARMAR KUSH10% owner
SaleCommon Stock 9,800 $28.75 $281,776.46
Disclosure

SEC source: 0001209191-20-036845 · doc4.xml · nonDerivative · entry 2

5AM Ventures IV, L.P. · CIK 0001589315 · 10% owner

5AM Co-Investors IV, L.P. · CIK 0001593361 · 10% owner

5AM Partners IV, LLC · CIK 0001589314 · 10% owner

DIEKMAN JOHN D · CIK 0001240357 · 10% owner

Schwab Andrew J. · CIK 0001598549 · 10% owner

5AM Opportunities I, L.P. · CIK 0001753000 · 10% owner

5AM Opportunities I (GP), LLC · CIK 0001790778 · 10% owner

PARMAR KUSH · CIK 0001664281 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 80,772

F2 · ownership.direct: 5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.

F3 · ownership.direct: Shares are held directly by 5AM Co-Investors IV, L.P.

F2 · ownership.nature: 5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.

F3 · ownership.nature: Shares are held directly by 5AM Co-Investors IV, L.P.

Read SEC document
June 11, 2020 Filed Jun 16, 2020 01:12 UTC
PARMAR KUSH10% owner
SaleCommon Stock 235,200 $28.75 $6,762,635.04
Disclosure

SEC source: 0001209191-20-036845 · doc4.xml · nonDerivative · entry 1

5AM Ventures IV, L.P. · CIK 0001589315 · 10% owner

5AM Co-Investors IV, L.P. · CIK 0001593361 · 10% owner

5AM Partners IV, LLC · CIK 0001589314 · 10% owner

DIEKMAN JOHN D · CIK 0001240357 · 10% owner

Schwab Andrew J. · CIK 0001598549 · 10% owner

5AM Opportunities I, L.P. · CIK 0001753000 · 10% owner

5AM Opportunities I (GP), LLC · CIK 0001790778 · 10% owner

PARMAR KUSH · CIK 0001664281 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,938,549

F1 · ownership.direct: Shares are held directly by 5AM Ventures IV, L.P.

F2 · ownership.direct: 5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.

F1 · ownership.nature: Shares are held directly by 5AM Ventures IV, L.P.

F2 · ownership.nature: 5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.

Read SEC document
June 11, 2020 Filed Jun 16, 2020 01:13 UTC
ROCKLAGE SCOTT MDirector · 10% owner
SaleCommon Stock 9,800 $28.75 $281,776.46
Disclosure

SEC source: 0001209191-20-036847 · doc4.xml · nonDerivative · entry 2

ROCKLAGE SCOTT M · CIK 0001219014 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnotes

Disclosed balance after: 80,772

F2 · ownership.direct: The reporting person is a managing member of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM Funds. The reporting person disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM Funds, except to the extent of his pecuniary interest therein.

F3 · ownership.direct: Shares are held directly by 5AM Co-Investors IV, L.P

F2 · ownership.nature: The reporting person is a managing member of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM Funds. The reporting person disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM Funds, except to the extent of his pecuniary interest therein.

F3 · ownership.nature: Shares are held directly by 5AM Co-Investors IV, L.P

Read SEC document
June 11, 2020 Filed Jun 16, 2020 01:13 UTC
ROCKLAGE SCOTT MDirector · 10% owner
SaleCommon Stock 235,200 $28.75 $6,762,635.04
Disclosure

SEC source: 0001209191-20-036847 · doc4.xml · nonDerivative · entry 1

ROCKLAGE SCOTT M · CIK 0001219014 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnotes

Disclosed balance after: 1,938,549

F1 · ownership.direct: Shares are held directly by 5AM Ventures IV, L.P.

F2 · ownership.direct: The reporting person is a managing member of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM Funds. The reporting person disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM Funds, except to the extent of his pecuniary interest therein.

F1 · ownership.nature: Shares are held directly by 5AM Ventures IV, L.P.

F2 · ownership.nature: The reporting person is a managing member of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM Funds. The reporting person disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM Funds, except to the extent of his pecuniary interest therein.

Read SEC document
May 19, 2020 Filed May 22, 2020 01:31 UTC
PARMAR KUSH10% owner
SaleCommon Stock 10,200 $35.15 $358,530.00
Disclosure

SEC source: 0001209191-20-031545 · doc4.xml · nonDerivative · entry 2

5AM Ventures IV, L.P. · CIK 0001589315 · 10% owner

5AM Co-Investors IV, L.P. · CIK 0001593361 · 10% owner

5AM Partners IV, LLC · CIK 0001589314 · 10% owner

DIEKMAN JOHN D · CIK 0001240357 · 10% owner

Schwab Andrew J. · CIK 0001598549 · 10% owner

5AM Opportunities I, L.P. · CIK 0001753000 · 10% owner

5AM Opportunities I (GP), LLC · CIK 0001790778 · 10% owner

PARMAR KUSH · CIK 0001664281 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 90,572

F2 · ownership.direct: 5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.

F3 · ownership.direct: Shares are held directly by 5AM Co-Investors IV, L.P.

F2 · ownership.nature: 5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.

F3 · ownership.nature: Shares are held directly by 5AM Co-Investors IV, L.P.

Read SEC document
May 19, 2020 Filed May 22, 2020 01:31 UTC
PARMAR KUSH10% owner
SaleCommon Stock 244,800 $35.15 $8,604,720.00
Disclosure

SEC source: 0001209191-20-031545 · doc4.xml · nonDerivative · entry 1

5AM Ventures IV, L.P. · CIK 0001589315 · 10% owner

5AM Co-Investors IV, L.P. · CIK 0001593361 · 10% owner

5AM Partners IV, LLC · CIK 0001589314 · 10% owner

DIEKMAN JOHN D · CIK 0001240357 · 10% owner

Schwab Andrew J. · CIK 0001598549 · 10% owner

5AM Opportunities I, L.P. · CIK 0001753000 · 10% owner

5AM Opportunities I (GP), LLC · CIK 0001790778 · 10% owner

PARMAR KUSH · CIK 0001664281 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,173,748

F1 · ownership.direct: Shares are held directly by 5AM Ventures IV, L.P.

F2 · ownership.direct: 5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.

F1 · ownership.nature: Shares are held directly by 5AM Ventures IV, L.P.

F2 · ownership.nature: 5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.

Read SEC document
May 19, 2020 Filed May 22, 2020 01:32 UTC SaleCommon Stock 10,200 $35.15 $358,530.00
Disclosure

SEC source: 0001209191-20-031546 · doc4.xml · nonDerivative · entry 2

ROCKLAGE SCOTT M · CIK 0001219014 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnotes

Disclosed balance after: 90,572

F2 · ownership.direct: The reporting person is a managing member of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM Funds. The reporting person disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM Funds, except to the extent of his pecuniary interest therein.

F3 · ownership.direct: Shares are held directly by 5AM Co-Investors IV, L.P

F2 · ownership.nature: The reporting person is a managing member of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM Funds. The reporting person disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM Funds, except to the extent of his pecuniary interest therein.

F3 · ownership.nature: Shares are held directly by 5AM Co-Investors IV, L.P

Read SEC document
May 19, 2020 Filed May 22, 2020 01:32 UTC SaleCommon Stock 244,800 $35.15 $8,604,720.00
Disclosure

SEC source: 0001209191-20-031546 · doc4.xml · nonDerivative · entry 1

ROCKLAGE SCOTT M · CIK 0001219014 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnotes

Disclosed balance after: 2,173,748

F1 · ownership.direct: Shares are held directly by 5AM Ventures IV, L.P.

F2 · ownership.direct: The reporting person is a managing member of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM Funds. The reporting person disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM Funds, except to the extent of his pecuniary interest therein.

F1 · ownership.nature: Shares are held directly by 5AM Ventures IV, L.P.

F2 · ownership.nature: The reporting person is a managing member of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM Funds. The reporting person disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM Funds, except to the extent of his pecuniary interest therein.

Read SEC document
May 18, 2020 Filed May 20, 2020 21:58 UTC OtherCommon Stock 1,734 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-064447 · a4.xml · nonDerivative · entry 5

Versant Vantage I, L.P. · CIK 0001765253 · 10% owner

Versant Vantage I GP, L.P. · CIK 0001777651 · 10% owner

Versant Vantage I GP-GP, LLC · CIK 0001777653 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 0

F8 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Vantage GP-GP without consideration to its members.

F7 · ownership.nature: The shares are held by Vantage GP-GP.

Read SEC document
May 18, 2020 Filed May 20, 2020 21:58 UTC OtherCommon Stock 1,734 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-064447 · a4.xml · nonDerivative · entry 4

Versant Vantage I, L.P. · CIK 0001765253 · 10% owner

Versant Vantage I GP, L.P. · CIK 0001777651 · 10% owner

Versant Vantage I GP-GP, LLC · CIK 0001777653 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,734

F6 · kind: Represents a change in the form of ownership of Vantage GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by Vantage GP.

F7 · ownership.nature: The shares are held by Vantage GP-GP.

Read SEC document
May 18, 2020 Filed May 20, 2020 21:58 UTC OtherCommon Stock 1,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-064447 · a4.xml · nonDerivative · entry 3

Versant Vantage I, L.P. · CIK 0001765253 · 10% owner

Versant Vantage I GP, L.P. · CIK 0001777651 · 10% owner

Versant Vantage I GP-GP, LLC · CIK 0001777653 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 0

F5 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Vantage GP without consideration to its partners.

F4 · ownership.nature: The shares are held by Vantage GP.

Read SEC document
May 18, 2020 Filed May 20, 2020 21:58 UTC OtherCommon Stock 1,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-064447 · a4.xml · nonDerivative · entry 2

Versant Vantage I, L.P. · CIK 0001765253 · 10% owner

Versant Vantage I GP, L.P. · CIK 0001777651 · 10% owner

Versant Vantage I GP-GP, LLC · CIK 0001777653 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,750

F3 · kind: Represents a change in the form of ownership of Vantage GP by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by Vantage.

F4 · ownership.nature: The shares are held by Vantage GP.

Read SEC document
May 18, 2020 Filed May 20, 2020 21:58 UTC OtherCommon Stock 116,664 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-064447 · a4.xml · nonDerivative · entry 1

Versant Vantage I, L.P. · CIK 0001765253 · 10% owner

Versant Vantage I GP, L.P. · CIK 0001777651 · 10% owner

Versant Vantage I GP-GP, LLC · CIK 0001777653 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,669

F1 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Vantage I, L.P. ("Vantage") without consideration to its partners.

F2 · ownership.direct: These Shares are directly held by Vantage. Versant Vantage I GP-GP, LLC ("Vantage GP-GP") is the general partner of Versant Vantage I GP, L.P. ("Vantage GP"), which is the general partner of Vantage. Each of Vantage GP-GP and Vantage GP may be deemed to indirectly beneficially own the shares beneficially owned by Vantage, but each disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.